БОЛЕЗНЬ СТИЛЛА, РАЗВИВШАЯСЯ У ВЗРОСЛЫХ

1. <div><p>Международная статистическая классификация болезней и проблем, связанных со здоровьем;10-й пересмотр. Женева: ВОЗ, 1995.</p><p>Efthimiou P., Paik P.K., Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.</p><p>Bannatyne G.A., Wohlmann A.S. Rheumatoid Arthritis: Its clinical history, etiology and pathology. Lancet 1896;1:1120-5.</p><p>Still G.F. On a form of chronic joint disease in children. Med Chir Trans 1897;80:47-65.</p><p>Reimann H.A., de Bardinis C.T. Periodic cyclic neutropenia, an entity. Blood 1949;4:1109-16.</p><p>Wissler H. Uber eine besondere Form sepsisahnlicher krankheiten (subsepsishyperergica). Z Kinderheilkd 1964;94:1-23.</p><p>Hegglin R., Uehlinger E. Klinische Demonstrationen: Febris periodica hyperergica. Schweiz Med Wschr 1964;94:675-85.</p><p>Fanconi G. Uber einen Fall von Subsepsis allergica Wissler. Helv Paediatr Acta 1946;1:532-7.</p><p>Riolet J. Syndrome de Wissler-Fanconi. Rev Rhum Mal Osteartic 1964;31:388-97.</p><p>Larson E.B. Adult Still's disease - recognition of a clinical syndrome and recent experience. West J Med 1985;142:665-71.</p><p>Wissler H. Subsepsis allergica. Ergeb Inn Med Kinderheilkd 1965;23:202-20.</p><p>Bywaters E.G. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.</p><p>Bywaters E.G. Categorization in medicine: A survey of Still's disease. Ann Rheum Dis 1967;26:185-93.</p><p>Bujak J.S., Aptekar R.G., Decker J.L. et al. Juvenile rheumatoid arthritis in theadult presenting as fever of unknown origin. Medicine (Baltimore) 1973;52:431-44.</p><p>Fabricant M.S., Chander S.B., Friou G.J. Still's disease in adults: A cause of prolonged undiagnosed fever. JAMA 1973;225:273-5.</p><p>Caroit M., Mathieu M., Kahn M.F. et al. Maladie de Still de l'adulte et syndrome de Wissler-Fanconi. Rev Rhum Mal Osteartic 1973;40:1-8.</p><p>Calabro J.J., Marchesano J.M. Fever associated with juvenile rheumatoid arthritis. N Engl J Med 1967;276:1-18.</p><p>Isdaile I.C., Bywaters E.G. The rash in Still's disease. Quart J Med 1956;25:377-87.</p><p>Calabro J.J., Cruess R.L., Levinson J.E. et al. Juvenile rheumatoid arthritis. Patient Care 1977;11:70-116.</p><p>Elkon K.B., Hughes G.R., Bywaters E.G. et al. Adult onset Still's disease: Twenty-year follow-up and further studies of patients with active disease. Arthr Rheum 1982;25:647-53.</p><p>Medsger T.A., Christy W.C. Carpal arthritis with ankylosis in late-onset Still's disease. Arthr Rheum 1976;19:232-42.</p><p>Healey L.A., Willkens R.F. Tarsal arthritis with ankylosis in late-onset Still's disease. Arthr Rheum 1982;25:1254-6.</p><p>Jamieson T.W. Adult Still's disease complicated by cardiac tamponade. JAMA 1983;249:2065-6.</p><p>Tesser J.R., Pisko E.J., Hartz J.W. et al. Chronic liver disease and adult Still's disease. Arthr Rheum 1982;25:579-82.</p><p>Baker D.G., Schumacher H.R., Reginato A.J. Fifteen patients with adult onset Still's disease: Life-threatening liver failure in two (Abstr). Arthr Rheum 1979;22:590.</p><p>Masson C., Le Loët X., Liote F. et al. Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed 1995;62:748-57.</p><p>Pelkonen P., Swanliung K., Siimes M.A. Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis. Acta Paediatr Scand 1986;75:64-8.</p><p>Gonzalez-Hernandez T., Martin-Mola E., Femandez-Zamoeano A. et al. Serum ferritin can be useful for diagnosis in adult onset Still's disease. J Rheumatol 1989;16:412-3.</p><p>Fautrel B., Le Moel G., Saint-Marcoux B. et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 2001;28:322-9.</p><p>Fautrel B. Ferritin levels in adult Still's disease: any sugar? J Bone Spine 2002;69:355-7.</p><p>Cush J.J. Adult-onset Still's disease. Bull Rheum Dis 2000;49:1-4.</p><p>Van Reeth C., Le Moel G., Lasne Y. et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's dis ease. J Rheumatol 1994;21:890-5.</p><p>Akritidis N., Giannakakis I., Giouglis T. Ferritin levels and response to treatment in patients with adult Still's disease. J Rheumatol 1996;23:201-2.</p><p>Magadur-Joly G., Billaud E., Barrier J.H. et al. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 1995;54:587-90.</p><p>Wakai K., Ohta A., Tamakoshi A. et al. Estimated prevalence and incidence of adult Still's disease: findings by anationwide epidemiological survey in Japan. J Epidemiol 1997;7:221-5.</p><p>Ohta A., Yamaguchi M., Tsunematsu T. et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63.</p><p>Van de Putte L.B., Wouters J.M. Adultonset Still's disease. Bailliere's Clin Rheumatol 1991;5:263-75.</p><p>Wouters J.M., van de Putte L.B. Adultonset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Quart J Med 1986;61:1055-65.</p><p>Sampalis J.S., Medsger T.A., Fries J.F. et al. Risk factors for adult Still's disease. J Rheumatol 1996;23:2049-54.</p><p>Kontzias A., Efthimiou P. Adult-Onset Still's Disease Pathogenesis, Clinical Manifestations and Therapeutic Advances. Drugs 2008;68:319-37.</p><p>Hoshino T., Ohta A., Yang D. et al. Elevated serum interleukin 6, interferongamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol 1998;25:396-8.</p><p>Ogata A., Kitano M., Yamanaka J. et al. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 2003;30:1093-6.</p><p>Kotter I., Wacker A., Koch S. et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthr Rheum 2007;37:189-97.</p><p>Jeon Y.K., Paik J.H., Park S.S. et al. Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol 2004;57:1052-6.</p><p>Jamin C., Morva A., Lemoine S. et al. Regulatory B lymphocytes in humans. A potential role in autoimmunity. Arthr Rheum 2008;58:1900-6.</p><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.</p><p>Cush J.J., Medsger T. Jr., Christy W.C. et al. Adult-onset Still's disease: clinical course and outcome. Arthr Rheum 1987;30:186-94.</p><p>Fautrel B., Zing E., Golmard J.L. et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore) 2002;81:194-200.</p><p>Pouchot J., Sampalis J.S., Beaudet F. et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-36.</p><p>Evensen K.J., Nossent H.C. Epidemiology and outcome of adult onset Still's disease in northern Norway. Scand J Rheumatol 2006;35:48-51.</p><p>Pay S., Turkcapar N., Kalyoncu M. et al. A multicenter study of patients with adultonset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006;25:639-44.</p><p>Mandl L., Esdaile J.M. Adult Still's disease. Up To Date. &lt;http://www.uptodate.com/&gt; (accessed 14 February 2006).</p><p>Kaplinsky N., Paas M., Frankl О. An adult form of juvenile rheumatoid arthritis. Arch Intern Med 1980;140:1073-4.</p><p>Khraishi M., Fam A.G. Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy. J Rheumatol 1991;18:1088-90.</p><p>Bambery P., Thomas R.J., Malhotra H.S. et al. Adult onset Still's disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 1992;51:529-32.</p><p>Shojania K., Chalmers A., Rangno K. Cyclosporin A in thetreatment of adult Still's disease. J Rheumatol 1995;22:1391-2.</p><p>Cefle A. Leflunomide and azathioprine combination in refractory adult-onset Still's disease. Ann Pharmacother 2005;39:764-7.</p><p>Murakami K., Fujii T., Yukawa N. et al. Successful treatment of a patient with refractory adult Still's disease by tacrolimus. The Japan Rheum. Association. Modern Rheumatol 2007;17:167-70.</p><p>Mahmud T., Hughes G.R. Intravenous immunoglobulin in thetreatment of refractory adult Still's disease. J Rheumatol 1999;26:2067-8.</p><p>Vignes S., Wechsler B., Amoura Z. et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal antiinflammatory drugs. Clin Exp Rheumatol 1998;16:295-8.</p><p>Bennett A.N., Peterson P., Sangle S. et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 2004;43:795-9.</p><p>Husni M.E., Maier A.L., Mease P.J. et al. Etanercept in the treatment of adult patients with Still's disease. Arthr Rheum 2002;46:1171-6.</p><p>Kuek A., Weerakoon A., Ahmed K. et al. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford) 2007;46:1043-4.</p><p>Cavagna L., Caporali R., Epis O. et al. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001;19:329-32.</p><p>Kokkinos A., Iliopoulos A., Greka P. et al. Successful treatment of refractory adultonset Still's disease with infliximab: a prospective, non-comparative series of four patients. Clin Rheumatol 2004;23:45-9.</p><p>Huffstutter J., Sienknecht C. Treatment of resistant adult Still's disease with infliximab: a report of 2 cases. J Clin Rheumatol 2004;10:218-21.</p><p>Bonilla Hernan M.G., Cobo Ibanez T., de Miguel Mendieta E. et al. Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease: experience in 2 cases [in Spanish]. Ann Med Interna 2004;21:23-6.</p><p>Caramaschi P., Biasi D., Carletto A. et al. A case of adult onset Still's disease treated with infliximab [letter]. Clin Exp Rheumatol 54. 54. 64</p><p>Fautrel B., Sibilia J., Mariette X. et al. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 2005;64:262-6.</p><p>Benucci M., Li G.F., Del Rosso A. et al. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheum 2005;23:733.</p><p>Efthimiou P., Georgy S. Pathogenesis and management of adult onset Still's disease. Semin Arthr Rheum 2006;36:144-52.</p><p>Godinho F., Santos M.J., Canas Da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.</p><p>Fitzgerald A.A., Leclercq S.A., Yan A. et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthr Rheum 2005;52:1794-803.</p><p>Iwamoto M., Nara H., Hirata D. et al. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthr Rheum 2002;46:3388-9.</p><p>Kraetsch H.G., Antoni C., Kalden J.R. et al. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 2001;60(Suppl. 3):55-7.</p><p>Dechant C., Schauenberg P., Antoni C.E. et al. Long-term out come of TNF blockade in adult-onset Still's disease [in German]. Dtsch Med Wschr 2004;129:1308-12.</p><p>Dilhuydy M.S., Vatan R., Etienne G. et al. Prolonged efficacy of infliximab for refractory adult-onset Still's disease. Clin Exp Rheumatol 2005;23:121-2.</p><p>Michel M., Duvoux C., Hezode C. et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 2003;30:1624-5.</p><p>Olivieri I., de Stefano G., Padula A. et al. Infliximab in a case of early adult-onset Still's disease. Clin Rheumatol 2003;22:369-70.</p><p>Serratrice J., Granel B., Disdier P. et al. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med 2003;115:589-90.</p><p>Kumari R., Uppal S.S. Prolonged remission in adult-onset Still's disease with etanercept. Clin Rheumatol 2006;25:106-8.</p><p>Asherson R.A., Pascoe L. Adult onset Still's disease: response to Enbrel. Ann Rheum Dis 2002;61:859-60.</p><p>Benucci M., Li G.F., Del Rosso A. et al. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report [letter]. Clin Exp Rheumatol 2005;23:733.</p><p>Haraoui B., Bourrelle D., Kaminska E. Anakinra in the treatmentof adult onset Still's disease. Ann Rheum Dis 2004;63(Suppl.):293-4.</p><p>Kotter I., Wacker A., Koch S. et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthr Rheum 2007;37:189-97.</p><p>Kalliolias G.D., Georgiou P.E., Antonopoulos I.A. et al. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrial. Ann Rheum Dis 2007;66:842-3.</p><p>Vasques Godinho F.M., Parreira Santos M.J., Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.</p><p>Rudinskaya A., Trock D.H. Successful treatment of a patient with refractory adultonset Still disease with anakinra. J Clin Rheumatol 2003;9:330-2.</p><p>Quartuccio L., De Vita S. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's disease. J Rheumatol 2007;34:892-3.</p><p>Chu C., Hughes G., Karr N. et al. Interleukin-1 blockade is an effective treatment of adult onset Still's disease. Arthr Rheum 2005;52:4101.</p><p>Lequerre T., Quartier P., Rosellini D. et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008;67:302-8.</p><p>Ahmadi-Simab K., Lamprecht P., Jankowiak C., Gross W.L. Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis 2006;65:1117-8.</p><p>Nakahara H., Mima T., Yoshio-Hoshino N. et al. A case report of a patient with refractory adult onset Still's disease who was successfully treated with tocilizumab over 6 years. Mod Rheumatol 2009;19:69-72.</p><p>De Bandt M., Saint-Marcouux B. Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 2009;68:153-4.</p><p>Priori R., Ceccarelli F., Baqrone F. et al. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease. Clin Exp Rheumatol 2008;26:933-7.</p><p>Bartoloni E., Alunno A., Luccioli F. et al. Successful treatment of refractory adultonset Still's disease with anti-CD20 monoclonal antibody. Clin Exp Rheumatol 2009;27:888-9.</p><p>Appenzeller S., Castro G., Costallat L. et al. Adult-onset Still disease in southeast Brazil. J Clin Rheumatol 2005;11:76-80.</p><p>Arkfeld D.G. The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 2008;28:205-15.</p><p>Kong X.D., Xu D., Zhang W. et al. Clinical features and prognosis in adultonset still's disease: a study of 104 cases. Clin Rheumatol 2010;29:1015-9.</p><p>Franchini S., Dagna L., Salvo F. et al. Efficacy of traditional and biological agents in different clinical phenotypes of adultonset Still's disease. Arthr Rheum 2010, Apr 29 [Epub. ahead of print].</p><p>Quartuccio L., Maset M., De Vita S. Efficacy of abatacept in a refractory case of adult-onset Still's disease. Clin Exp Rheumatol 2010;28:265-7.</p><p>Ak O., Ozer S., Cag Y., Karagöz G. An adult onset Still's disease mimicking pneumonia. Rheumatol Int 2010, Apr 2 [Epub. ahead of print].</p><p>Муравьев Ю.В., Жуковская Г.Н., Лебедева В.В. О синдроме Стилла у взрослых. Ревматология 1991;1:37-40.</p><p>Carli L., Rizelli G.M.L., d'Ascanio A. et al. Adult onset Still'disease: analysis of a monocentric cohort. Ann Rheum Dis 2010;69(Suppl. 3):716.</p><p>Salvin S., Quartuccio L., Moroldo T. et al. Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset Still's disease. Ann Rheum Dis 2010;69(Suppl. 3):710.</p><p>Perdan-Pirkmajer K., Praprotnik S., Tomsic M. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010, Aug 24 [Epub. ahead of print].</p><p>Kobayashi M., Takahashi Y., Yamashita H. et al. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol 2010, Aug 26 [Epub. ahead of print].</p><p>Sumida K., Ubara Y., Hoshino J. et al. Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol 2010, Mar 12 [Epub. ahead of print].</p><p>Matsumoto K., Nagashima T., Takatori S. et al. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab. Clin Rheumatol 2009;28:485-7.</p><p>Yoshimura M., Makiyama J., Koga T. et al. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD). Clin Exp Rheumatol 2010;28:141-2.</p><p>Puechal X., de Bandt M., Berthelot J.M. et al. Tocilizumab in refractory adult Still's disease. Arthr Care Res (Hoboken) 2010, Aug 25 [Epub. ahead of print].</p></div><br />